Replies to post #201193 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Developing a drug with similar MOA to those Anavex own would be a lengthy process with the risk of being late and infringing on IP.

Acquisition or partnership would seem more a likely solution for a BP like Eisai.